Restylane
AssetAlso Emervel, Restylane or Emervel filler, Restylane/Emervel filler
Hyaluronic acid dermal filler providing volume restoration and aesthetic correction of facial tissue.
- Stage
- Phase 3
- Modality
- Device
- Target
- Not known
- 2
- Indications
- 112
- Trials
- 1
- Developer
Indications
2Aesthetic
Phase 3, Completed, NCT02297516, clinicaltrials.gov, 7 Oct 2026
Facial aesthetic treatment
Phase 3, Completed, NCT02297503, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials112
- Evidence for its targets1
- Competitors1
- Signals13
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026, 3 sources